Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2025-12-24 @ 7:41 PM
NCT ID:
NCT01816503
Eligibility Criteria:
Inclusion Criteria:
* Patients complaining of cancer pain which requires administration of long-acting opioid analgesics
* Patients whose pain is not sufficiently controlled despite administration of strong long-acting opioid analgesics
* Patients who are deemed to need an initial minimum dose of fentanyl matrix 75 micrograms/h
* Patients who signed the informed consent form
Exclusion Criteria:
* Patients with a history of or current drug or alcohol abuse
* Childbearing women who are pregnant or likely to be pregnant during the study period and men who are neither infertile nor willing to refrain from sexual relations but whose partner does not conduct an effective contraception
* Patients who are unable to use a transdermal system due to skin disease
* Patients with history of hypersensitivity to opioid analgesics
* Patients who are not eligible for the study participation based on warnings, precautions and contraindications in the package insert of the study drug at the investigator's discretion
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT01816503
Study Brief:
Protocol Section:
NCT01816503